SREINFRA - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors

KABRAEXTRU - Announcement under Regulation 30 (LODR)-Press Release / Media Release

DLF - Announcement under Regulation 30 (LODR)-Newspaper Publication

FOSECOIND - Board Meeting Intimation for 1. To Approve And Take On Record The Audited Financial Results Of The Company For The Quarter #Part1

BAJAJ-AUTO - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

ADANIENT - Submission Of Media Statement By Mr. Jatin Jalundhwala, Group Head - Legal, Adani

DRREDDY - Form 6-K For The Quarter Ended December 31, 2022, Filed With United States Securities And Exchange Commission.

BASF - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

ELANTAS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

HINDUNILVR - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

HINDUNILVR - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BLUEDART - Intimation Under Regulation 30 Of The Securities & Exchange Board Of India (Listing Obligations & Disclosure Requirements) #Part1

SCAPDVR - INTIMATION PURSUANT TO THE REGULATION 47 OF THE SECURITIES AND EXCHANGE BOARD OF INDIA ("SEBI") (LISTING OBLIGATIONS AND #Part1

AARTIDRUGS - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

COLPAL - Clarification To Outcome Of Board Meeting Dated 24Th January, 2023

INDIGO - Board Meeting Intimation for Intimation For Board Meeting And Earnings Call Under Regulation 29 And 30 Of The SEBI (Listing #Part1

M&M - Transfer Of Equity Shares By Mahindra & Mahindra Employees' Stock Option Trust To The Stock Option Grantees

LEMONTREE - Board Meeting Intimation for Intimation Regarding Holding Of Meeting Of The Board Of Directors, Inter Alia, To Consider #Part1

VGUARD - Board Meeting Intimation for Consider And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company #Part1

TORNTPHARM - Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter And Nine Months Ended #Part1